Correction to :β adrenergic receptor kinase C-terminal peptide gene-therapy improves ß2-adrenergic receptor-dependent neoangiogenesis after hindlimb ischemia (Journal of Pharmacology and Experimental Therapeutics (2016) 356:2 (503–513) DOI: 10.1124/jpet.115.228411)

Autor: Cannavo A., Liccardo D., Lymperopoulos A., Gambino G., D'Amico M. L., Rengo F., Koch W. J., Leosco D., Ferrara N., Rengo G.
Přispěvatelé: Cannavo, A., Liccardo, D., Lymperopoulos, A., Gambino, G., D'Amico, M. L., Rengo, F., Koch, W. J., Leosco, D., Ferrara, N., Rengo, G.
Jazyk: angličtina
Rok vydání: 2019
Popis: In the above article [Cannavo A, Liccardo D, Lymperopoulos A, Gambino G, D’Amico ML, Rengo F, Koch WJ, Leosco D, Ferrara N, and Rengo G (2016) J Pharmacol Exp Ther 356(2): 503–513; DOI: 10.1124/jpet.115.228411], the following funding information was omitted: This work was funded by the National Institutes of Health [Grant R37 HL061690]. The authors regret this error and any inconvenience it may have caused.
Databáze: OpenAIRE